• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

Becton Dickinson

Pfizer collaborates to improve access to injectable contraceptive

May 9, 2017 By Sarah Faulkner

Pfizer

Pfizer (NYSE:PFE) said yesterday that it inked a multi-year extension of its collaboration with the Bill & Melinda Gates Foundation and the Children’s Investment Fund Foundation to improve access to the company’s injectable contraceptive, Sayana Press, for women in developing countries. The pharma giant’s product uses Becton Dickinson‘s (NYSE:BDX) Uniject delivery system to administer a long-acting, […]

Filed Under: Auto-injectors, Distribution, Drug-Device Combinations, Featured, Pharmaceuticals, Wall Street Beat, Women's Health Tagged With: Becton Dickinson, Pfizer Inc.

Becton Dickinson to acquire Bard in $24B deal

April 24, 2017 By Sarah Faulkner

C.R. Bard and Becton Dickinson

Becton Dickinson (NYSE:BDX) has inked an agreement with C. R. Bard (NYSE:BCR) to acquire the medtech company for $317.00 per Bard common share in cash and stock, valuing the deal at $24 billion. In announcing the deal yesterday, Franklin Lakes, N.J.-based BD said it plans to create a new segment within the company, BD Interventional, to […]

Filed Under: Drug-Device Combinations, Featured, Mergers & Acquisitions Tagged With: Becton Dickinson, C.R. Bard

Becton Dickinson warns customers about injury reports from Eclipse needle

April 18, 2017 By Sarah Faulkner

BD's Eclipse needle

Becton Dickinson warned customers and business partners that it has received reports of needlestick injury for its BD Eclipse needle, used in transfusion procedures. Arrow International, which uses BD’s Eclipse needle devices in certain products, wrote to its customers today to inform them of the injury reports. Based on customer reports, BD said that in […]

Filed Under: Featured, Hospital Care, Wall Street Beat Tagged With: Becton Dickinson

Pharma stocks fall on Trump’s proposal to cut NIH budget

March 16, 2017 By Sarah Faulkner

Pharma stocks fall on Trump's proposal to cut NIH budget

The Trump budget plan to slash more than 18% from the budget for the National Institutes of Health sent pharmaceutical stocks down today on Wall Street as investors reacted to the proposal. The budget proposal, released today, would cut the NIH budget by $5.8 billion, to $25.9 billion – an 18.3% cut. The proposal would also introduce […]

Filed Under: Featured, Policy, Wall Street Beat Tagged With: Abbott Laboratories, Amgen, Becton Dickinson, Biogen Idec, Boston Scientific, C.R. Bard, Gilead Sciences, johnsonandjohnson, Medtronic, Merck, Pfizer Inc.

GCMI and BD to support medtech startups in Southeast U.S.

March 3, 2017 By Danielle Kirsh

The Global Center for Medical Innovation has partnered with Becton, Dickinson and Co. (BD) to support the launch of the GCMI Medtech Accelerator. “Too many medtech startups fail unnecessarily due to a lack of bridge, or seed funding, required to advance far enough in the commercialization process to attract investment by a larger device company,” […]

Filed Under: Big Data Tagged With: Becton Dickinson, Dickinson and Co., GCMI, Global Center for Medical Innovation, medtech

DoD taps BD’s Pyxis for $100m medication dispensing contract

March 3, 2017 By Sarah Faulkner

Becton Dickinson

Becton Dickinson & Co. (NYSE:BDX) said today that it won a $100 million contract from the U.S. Department of Defense for its Pyxis ES system. According to the contract, Franklin Lakes, N.J.-based BD will provide its medication dispensing technology to 115 military inpatient health facilities and military inpatient pharmacies. Get the full story at our sister […]

Filed Under: Featured, Pharmaceuticals, Wall Street Beat Tagged With: Becton Dickinson, U.S. Department of Defese

Collecting purposeful data in the era of connected health devices

February 16, 2017 By Sarah Faulkner

Collecting purposeful data in the era of connected health devices

Connectivity, one of the newest buzzwords in the medical device lexicon, is becoming more and more integral to device design and development. Research shows that connected health devices can improve patient outcomes by increasing adherence and reducing dosing variability. Mark David Tuckwell, head of electronics, software & systems at Sagentia, says connected device can also provide crucial information to help […]

Filed Under: Drug-Device Combinations, Featured, Pharmaceuticals, Wall Street Beat Tagged With: Adherium, Baxter International, Becton Dickinson, Companion Medical, GlaxoSmithKline plc, Propeller Health, Sagentia, Sanofi-Aventis

Early collaboration is key in drug-device development, experts say

February 15, 2017 By Sarah Faulkner

Industry leaders talk partnerships, collaboration in drug delivery

While pharmaceutical companies and medical device firms know that working together is a vital part of doing business, they “live in 2 different world in many ways,” Minnetronix co-founder Dirk Smith said last week at the annual Drug Delivery Partnerships conference. From development timelines to regulatory approval pathways, it can sometimes seem like pharma and medtech companies are […]

Filed Under: Drug-Device Combinations, Featured, Pharmaceuticals, Wall Street Beat Tagged With: Baxter International, Becton Dickinson, GlaxoSmithKline plc, Minnetronix, Sanofi-Aventis

BD launches high volume syringe for biologics

December 15, 2016 By Sarah Faulkner

Becton Dickinson

Becton Dickinson (NYSE:BDX) said today that it launched its BD Neopak 2.25 milliliter prefillable glass syringe designed for high-volume injection of biologics. The Franklin Lakes, N.J.-based company said that its prefillable glass syringe was developed to reduce drug degradation and aggregation between the container and therapeutic. The high volume syringe is commercially available in the […]

Filed Under: Drug-Device Combinations, Featured, Pharmaceuticals, Technology, Wall Street Beat Tagged With: Becton Dickinson

BD’s Pyxis ES drug pump adopts Internet of Things

December 1, 2016 By Sarah Faulkner

Becton Dickinson

Becton Dickinson (NYSE:BDX) said today that it adopted the Windows 10 Internet of Things operating system for its automated drug-dispensing Pyxis ES system. The new operating system features long-term support and improved cybersecurity. The Windows 10 Internet of Things operating system boasts a 10-year support package and active security patches. It also offers new features […]

Filed Under: Drug-Device Combinations, Featured, Hospital Care, mHealth (Mobile Health), Pharmaceuticals, Technology Tagged With: Becton Dickinson

  • « Go to Previous Page
  • Page 1
  • Interim pages omitted …
  • Page 3
  • Page 4
  • Page 5
  • Page 6
  • Go to Next Page »

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS